HARVARD BIOSCIENCE INC — Director's Dealing 2015

Apr 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2015-04-15

Reporting Person: GREEN DAVID (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-15	Common Stock	S	15700	$6.53	Disposed	798553	Direct
2015-04-16	Common Stock	S	21303	$6.59	Disposed	777250	Direct
2015-04-17	Common Stock	S	5500	$6.49	Disposed	771750	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	322124	Indirect
Common Stock	300000	Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $6.45 to $6.59. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: Includes (a) a deferred stock award of 19,400 restricted stock units which vest on May 30, 2015; (b) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (c) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; and (d) 722,563 shares of common stock held by the Reporting Person.

F3: This transaction was executed in multiple trades at prices ranging from $6.51 to $6.62. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: Includes (a) a deferred stock award of 19,400 restricted stock units which vest on May 30, 2015; (b) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (c) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; and (d) 701,260 shares of common stock held by the Reporting Person.

F5: This transaction was executed in multiple trades at prices ranging from $6.38 to $6.60. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: Includes (a) a deferred stock award of 19,400 restricted stock units which vest on May 30, 2015; (b) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (c) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; and (d) 695,760 shares of common stock held by the Reporting Person.